(Q36128822)

12 August 2017

1 reference

title

The management of bipolar disorder in primary care: a review of existing and emerging therapies (English)

1 reference

12 August 2017

1 reference

Lesley Berk

3

0 references

Michael Berk

object named as

Michael Berk

series ordinal

1

0 references

Seetal Dodd

series ordinal

2

object named as

Seetal Dodd

1 reference

12 August 2017

1 June 2005

1 reference

Psychiatry and Clinical Neurosciences

12 August 2017

1 reference

12 August 2017

59

1 reference

12 August 2017

3

1 reference

12 August 2017

229-239

1 reference

Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Prophylaxis of bipolar disorder: how and who should we treat in the long term?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Maintenance therapies for classic and other forms of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Does lithium treatment still work? Evidence of stable responses over three decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Is there a loss of efficacy of lithium in patients treated for over 20 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

The place of anticonvulsant therapy in bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Valproate in the treatment of acute mania. A placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Depression during mania. Treatment response to lithium or divalproex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

A review of randomized, controlled clinical trials in acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Pharmacologic agents for the treatment of acute bipolar mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

An open study of lamotrigine in refractory bipolar depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Controlled trials in bipolar I depression: focus on switch rates and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Lamotrigine plasma levels reduced by oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Topiramate in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Open-label adjunctive topiramate in the treatment of bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Gabapentin in the acute treatment of refractory bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Gabapentin treatment of the non-refractory bipolar spectrum: an open case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Treatment non-adherence in affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Patient and physician attitudes toward lithium: relationship to compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Case for caution, case for action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Life events and the course of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes: a preliminary investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Sleep reduction as a final common pathway in the genesis of mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Family factors and the course of bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

The effect of episodes on recurrence in affective disorder: a case register study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Mood stabilization and weight loss with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

A double-blind comparison of valproate and lithium in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Tranylcypromine versus imipramine in anergic bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

Lithium use and discontinuation in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2005.01365.X

10.1111/J.1440-1819.2005.01365.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15896214